가용성 마이크로캐리어 시장 보고서 : 동향, 예측 및 경쟁 분석(-2035년)

Dissolvable Microcarrier Market

The future of the global dissolvable microcarrier market looks promising with opportunities in the cell therapy and vaccine production markets. The global dissolvable microcarrier market is expected to reach an estimated $171.7 million by 2035 from $61.4 million in 2027 with a CAGR of 11.4% from 2027 to 2035. The major drivers for this market are the increasing demand for advanced cell therapy applications, the rising use in regenerative medicine manufacturing, and the growing adoption in biopharmaceutical production processes.

• Lucintel forecasts that, within the type category, GMP grade is expected to witness higher growth over the forecast period due to growing regulatory pressure to adopt GMP manufacturing processes for cell therapies.
• Within the application category, cell therapy is expected to witness the highest growth over the forecast period due to increasing demand for scalable processes for cell therapy manufacturing.
• In terms of regions, APAC is expected to witness the highest growth over the forecast period due to increase in cell therapy manufacturing and biotechnology investment.

Emerging Trends in Dissolvable Microcarrier Market

The market for dissolvable microcarriers is transitioning from research-use consumables to products used in the large-scale production of cell-based therapies. Between 2025 and 2027, expectations are that the technology would allow for reliable and repeatable closed-system release of the microcarriers and low downstream processing. Lucintel forecasts that the biomanufacturing industry will increasingly adopt single-use, application-specific automation and integration.

• Sustainability: In 2025, suppliers will probably promote the use of dissolvable polymers to coat cell culture substrates. Compared to other culture methods that require the use of chemical and/or enzymatic treatments to release adhered cells, this method will likely reduce the amount of solid waste generated in the laboratory.
• Automation: With the commercialization of automated microcarrier-handling systems during the same year, expectations will probably increase for the large-scale, automated harvest and seeding of microcarriers by bioprocess engineers.
• Functional Materials: In 2025, the control of microcarrier dissolution will likely be further enhanced with the incorporation of cell-adhesion ligands. The performance of these materials will likely determine the extent of the commercialization of microcarriers for cell and tissue bioprocessing.
• Closed Manufacturing: By 2026, CMOs will integrate dissolvable microcarriers into closed, single-use bioprocesses. Contamination, the need for rigorous documentation, and lengthy changeover times will be major concerns for CMOs processing advanced therapies. As such, CMOs will need to ensure their bioprocesses meet the required standards.
• Specialization: From 2025 to 2027, suppliers will manufacture carriers specifically for mesenchymal and induced pluripotent stem cells and organoids. Suppliers will be able to charge more for carriers because of increased specialization. The carriers will need to meet stringent requirements for potency and recovery.

Prior to the general availability of dissolvable microcarriers, the microcarriers will need to be validated for several parameters. These parameters will be process economics, especially cell recovery and sterility. The supplier will need to integrate automation for process economics. The regulation will drive a competitive market for both processing and lab consumables. Suppliers will need to integrate multi-year designs and partnerships to create customized processes for clients.

Recent Developments in the Dissolvable Microcarrier Market

By 2027, the market for dissolvable microcarriers will increase to help commercial-scale cell therapies break through the bottlenecks associated with current manufacturing methods. In Lucintel's opinion, the market will shift from lab-scale microcarriers to commercial-scale microcarriers. Significant progress in this area will also depend on improvements in large-scale manufacturing and the supply of microcarriers at an economical price.

• Cell Therapy Manufacturing: In 2025, Sartorius announced it would spend over 2 billion euros to increase its capacity to manufacture biopharmaceutical equipment and reagents by 2025. This will increase the demand for single-use bioprocessing equipment, which will, in turn, increase the demand for dissolvable microcarriers.
• Process Integration: In 2025, many bioprocessing equipment manufacturers launched single-use bioprocessing systems designed to integrate large (2,000 L) bioreactors. To support these systems, the bioprocessing industry will adopt dissolvable microcarriers to improve batch turnaround times and reduce contamination.
• Scale-up of Regenerative Medicines: The approval of multiple cell therapies by the FDA will stimulate the development of other adherent stem cell and tissue-based therapies, increasing the demand for related microcarriers.
• Commercial Partnerships: In 2025, more collaborations occurred among material and cell-processing companies to create Advances in surface modifications and automation of material-handling processes. Since no company currently controls the entire platform, these business partnerships allow companies to develop customized carrier formulations and combined process offerings.
• Advances in Biodegradable Materials: Development in biodegradable materials for cell-therapy products has focused on control of the particle size, carrier formulation and degree of degradability of the polymer. Hydrogels and other naturally-occurring products have gained increased attention for use as polymer carriers. Loss of carrier materials can help improve the recovery of encapsulated cells, especially in the case of manual removal of carrier materials.

There is a need to focus on the downstream processing of cell-based therapies. This includes the validation of the manufacturing processes, supplies and materials. Lot-to-lot uniformity of suppliers along with the ability of the suppliers to demonstrate the compatibility of their products with various methods of sterilization and storage will allow the suppliers to gain a competitive edge in the marketplace.

Strategic Growth Opportunities in the Dissolvable Microcarrier Market

The market is expected to significantly grow beyond 2026. As process and economic challenges limit the clinical advancement of therapeutic candidates, the demand for manufacturing services is expected to increase. As stated by Lucintel, increasing market needs can be fulfilled by utilizing micro and nano structurers as scaffolds, thus simplifying and improving the volume of production.

• Cell Therapy Manufacturing: The use of dissolvable microcarriers can lead to the large scale expansion of stem cells and reduce the number of steps required for cell separation. As stated by the FDA, as of January 2025, there were 2000 ongoing Clinical Trials for cell and gene therapy. It is expected that in the next 5 years, biopharmaceutical companies will use cell micro and nano carriers for the manufacture of cell therapies.
• Regenerative Medicine: Carriers that are not retrievable have many applications in regenerative medicine. In January 2025, the FDA approved 30 products.
• Xeno-free Products: Clinical manufacturers are adopting chemically defined, more tightly controlled raw materials. The 2025 edition of the European Pharmacopoeia contained more than 2,500 monographs. This will reward manufacturers that provide documented supply chains, low levels of endotoxins, and evidenced dissolution.
• Asia-Pacific Region: The capability of biologics in South Korea, India and Singapore is rapidly expanding. In February 2025, biomedical manufacturing in Singapore reached an annual worth of over 20 billion dollars. The adoption of advanced biologics will increase in other regions as technological and supply agreements overwhelm traditional manufacturing areas.
• Automation: The bioprocessing market, led by the development of microcarriers and sensors, will enable fully automated systems. In the next 3-5 years, automation will accelerate the use of continuous bioprocessing. Documented supply and yield will be the most critical factors for customer choice. Price will not be the primary factor.

When flexibility and scalability are paramount to success, partners are essential. Contract Manufacturing Organizations (CMOs) should help customers develop processes to manufacture at commercial scales. Supply reliability, documentation and yield will determine the success of the partnership.

Dissolvable Microcarrier Market Drivers and Challenges

Lucintel expects the Emerging Market for Dissolvable Microcarriers to Contribute to Advances in Bioprocessing and/or Meet Growing Demand for Cell and Gene Therapies. Areas of focus such as process and product-related sustainability, refining biomaterials, and design-for-manufacturability will create new market spaces for scalable production. Although many opportunities exist, traditional barriers such as investment, validation, and performance will continue to harness market growth.

The factors responsible for driving this market include :

• Increased Demand for Three-dimensional Expansion of Cells: Cultured biologics, cell therapies and vaccines are some of the quickest growing areas in the biomedical industry. As of 2025, more than 7000 cell and gene therapy clinical trials were reported. Expanding commercial and clinical manufacturing of cell therapies increases the need for scalable cell culture technologies and processes. Bioprocessing technologies that incorporate dissolvable microcarriers to enable improved cell recovery and ease of harvest are expected to gain popularity in the near to medium term.
• Improvements in Biotechnology: Biotechnology is advancing to create artificial substrates that enhance the attachment and proliferation of cells and enable controlled release. In 2025, researchers evaluated microcarriers (typically 100 to 300 micrometers in size) for cell culture. It is likely that in the succeeding 3 to 5 years, the microcarrier systems allied with single-use bioreactors would enable the production of genetic therapies and cellular pharming.
• Favorable Regulations: In 2025, U.S. regulators continued to permit more than 30 cellular and gene therapies, thereby pressing product sponsors to develop scalable and reliable processes. It is expected that in the ensuing 3 to 5 years, reliance on microcarriers in bioprocessing would increase, and more stringent tests on starting materials would enable the use of microcarriers in bioprocessing.
• Sustainability: There is a generally held view that processes involving the use of biopharmaceuticals would benefit from reduced consumption and increased efficiency of resources. Use of single-use, disposable bioprocessing systems has increased. In the 3 to 5 year outlook, use of dissolvable microcarriers would likely increase and enable processes to achieve better sustainability goals.
• Improving Manufacturing Efficiency: Dissolvable microcarriers streamline cell harvesting by eliminating or minimizing steps like filtration, centrifugation, and enzymatic detachment. As of 2025, biologics productions involving large-scale (>2000L) bioreactors remained prevalent, indicating insufficient cell expansion technologies. In the short term (3-5 years), further development of the technology may help simplify large-scale production of biologics and reduce the number of personnel required for cell culture.

The challenges facing this market include:

• High Production Costs: Complex, expensive processes to functionalize and produce dissolvable microcarriers (including sterilization and testing) lead to high costs. Long, 5+ year, development times prior to market launch to validate the platforms heightened the financial risks. 2025 was representative of the trend; further, the costs and complexities of production, functionalization, and validation heightened risks and slowed the adoption of the technology by small to medium biotech companies.
• Reliability and Consistency: In 2025, achieving the desired outcomes across a range of cell types and products remained a significant challenge for many biopharma companies. Variability in the dissolution of microstructural supports resulted in differences in the growth and recovery of cells. During the same time period, to achieve the desired performance, many companies engaged in numerous, extensive and costly process development activities.
• Relatively Little Standardization and Lack of Technical Know-how: Currently, there are no standard ways to test the behavior of microcarriers and cell adhesion, storage and long-term stability, and the performance of microcarrier-based systems in downstream processes. In 2025, there were numerous microcarrier-based processes, which, due to the use of different types of polymers, coatings and additives as well as varying process conditions, made a comparison of these processes very difficult. It is possible that, within the next 3 to 5 years, the lack of adequate staff and the use of different and inadequate evaluation methods will hinder the completion of reviews and approvals by regulatory authorities, and therefore the use of microcarriers in the manufacture of pharmaceuticals. The use of generally accepted rules, standard procedures and the training of personnel will remove the barriers that limit the commercial use of microcarriers.

The growing use of biopharmaceutical and cell therapies will create a greater need for more efficient methods for expanding the cells used in these products. The same will be true for the manufacturing of gene therapies, vaccines and other complex biologics. Improvements in dissolvable microcarriers, as well as advances in biotechnology and pharmaceutical regulations, manufacturing and related services, will enhance the use of these products. The overall level of integration, performance and consistency of products, and the commitment of suppliers to sustainability will determine the success of dissolvable microcarrier manufacturers.

List of Dissolvable Microcarrier Market Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. Through these strategies dissolvable microcarrier market companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the dissolvable microcarrier market companies profiled in this report include-

• Corning
• CytoNiche
• Tantti Laboratory
• IamFluidics
• DNP

Dissolvable Microcarrier Market by Segment

The study includes a forecast for the global dissolvable microcarrier market by type, application, and region.

Dissolvable Microcarrier Market by Type [Value ($M) from 2019 to 2035]:

• GMP Grade
• Non-GMP Grade

Dissolvable Microcarrier Market by Application [Value ($M) from 2019 to 2035]:

• Cell Therapy
• Vaccine Production
• Others

Dissolvable Microcarrier Market by Region [Value ($M) from 2019 to 2035]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

Country Wise Outlook for the Dissolvable Microcarrier Market

The market for dissolvable microcarriers is expected to grow with the expansion of the scalable manufacturing of cell therapy and other related industries. There will be increased demand between 2025 and 2027 for carriers that help recover cells and minimize complexity of downstream processes. According to Lucintel, advancements in these areas will primarily influence and drive the market.

• United States: The U.S. government has issued numerous awards and funding through the 2021-2025 America Competes Act. The Defense Department, as part of the Biomanufacturing program, awarded $4.9 billion in contracts in February 2025 to facilitate the construction of biomanufacturing facilities. This will lead to an increased use of dissolvable microcarriers in the cell therapy and gene therapy industries.
• China: The 13th (2016-2020) and the recently concluded 14th (2021-2025) China's Five-Year Plan defined and focused on biotechnology, including the cell therapy and related industries. The 2025 Work Report of the 19th Central Committee of the Communist Party of China allocated 398.7 billion yuan to encourage and facilitate the continued development of biotechnology and other related industries.
• Germany: Sartorius announced in February 2025 that it would spend €3.4 billion by 2024 and build additional manufacturing facilities in Germany. Bioprocessing companies are positioning manufacturing facilities in Europe to meet increasing customer demand. Sartorius is one of the few companies in Europe that manufactures single-use and dissolvable bioprocessing technologies, and is investing to expand its capacity.
• India: The Indian government's Biopharmaceutical Ecosystem of India (BioE3) policy for 2024 encourages the manufacture of biopharmaceuticals. The government set aside ₹10,000 crore for this policy. The cell-culture manufacture of biopharmaceuticals requires sophisticated consumables, which, with this policy, will become available. Cell-culture technologies and manufacturing processes are as important as the downstream bioprocessing technologies. This policy will also spur the development of these technologies.
• Japan: Japan, similarly, has increased funding for biotechnology and cell processing. The government's 2025 budget increased funding for regenerative medicine from the previous year's budget. The increasing funding will facilitate research for manufacturing cell therapeutics and reduce reliance on imports. Japan will also expand its resource recovery-friendly microcarriers.

Features of the Global Dissolvable Microcarrier Market

• Market Size Estimates: dissolvable microcarrier market size estimation in terms of value ($B).
• Trend and Forecast Analysis: Market trends (2019 to 2026) and forecast (2027 to 2035) by various segments and regions.
• Segmentation Analysis: dissolvable microcarrier market size by type, application, and region in terms of value ($B).
• Regional Analysis: dissolvable microcarrier market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
• Growth Opportunities: Analysis of growth opportunities in different types, applications, and regions for the dissolvable microcarrier market.
• Strategic Analysis: This includes M&A, new product development, and competitive landscape of the dissolvable microcarrier market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

If you are looking to expand your business in this or adjacent markets, then contact us. We have done hundreds of strategic consulting projects in market entry, opportunity screening, due diligence, supply chain analysis, M & A, and more.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the dissolvable microcarrier market by type (GMP grade and non-gmp grade), application (cell therapy, vaccine production, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 8 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Market Overview

• 2.1 Background and Classifications
• 2.2 Supply Chain

3. Market Trends & Forecast Analysis

• 3.1 Macroeconomic Trends and Forecasts
• 3.2 Industry Drivers and Challenges
• 3.3 PESTLE Analysis
• 3.4 Patent Analysis
• 3.5 Regulatory Environment

4. Global Dissolvable Microcarrier Market by Type

• 4.1 Overview
• 4.2 Attractiveness Analysis by Type
• 4.3 GMP Grade : Trends and Forecast 2019 to 2035
• 4.4 Non-GMP Grade : Trends and Forecast 2019 to 2035

5. Global Dissolvable Microcarrier Market by Application

• 5.1 Overview
• 5.2 Attractiveness Analysis by Application
• 5.3 Cell Therapy : Trends and Forecast 2019 to 2035
• 5.4 Vaccine Production : Trends and Forecast 2019 to 2035
• 5.5 Others : Trends and Forecast 2019 to 2035

6. Regional Analysis

• 6.1 Overview
• 6.2 Global Dissolvable Microcarrier Market by Region

7. North American Dissolvable Microcarrier Market

• 7.1 Overview
• 7.2 North American Dissolvable Microcarrier Market by Type
• 7.3 North American Dissolvable Microcarrier Market by Application
• 7.4 The United States Dissolvable Microcarrier Market
• 7.5 Canadian Dissolvable Microcarrier Market
• 7.6 Mexican Dissolvable Microcarrier Market

8. European Dissolvable Microcarrier Market

• 8.1 Overview
• 8.2 European Dissolvable Microcarrier Market by Type
• 8.3 European Dissolvable Microcarrier Market by Application
• 8.4 German Dissolvable Microcarrier Market
• 8.5 French Dissolvable Microcarrier Market
• 8.6 Italian Dissolvable Microcarrier Market
• 8.7 Spanish Dissolvable Microcarrier Market
• 8.8 The United Kingdom Dissolvable Microcarrier Market

9. APAC Dissolvable Microcarrier Market

• 9.1 Overview
• 9.2 APAC Dissolvable Microcarrier Market by Type
• 9.3 APAC Dissolvable Microcarrier Market by Application
• 9.4 Chinese Dissolvable Microcarrier Market
• 9.5 Indian Dissolvable Microcarrier Market
• 9.6 Japanese Dissolvable Microcarrier Market
• 9.7 South Korean Dissolvable Microcarrier Market
• 9.8 Indonesian Dissolvable Microcarrier Market

10. ROW Dissolvable Microcarrier Market

• 10.1 Overview
• 10.2 ROW Dissolvable Microcarrier Market by Type
• 10.3 ROW Dissolvable Microcarrier Market by Application
• 10.4 Middle Eastern Dissolvable Microcarrier Market
• 10.5 South American Dissolvable Microcarrier Market
• 10.6 African Dissolvable Microcarrier Market

11. Competitor Analysis

• 11.1 Product Portfolio Analysis
• 11.2 Operational Integration
• 11.3 Porter's Five Forces Analysis
  • Competitive Rivalry
  • Bargaining Power of Buyers
  • Bargaining Power of Suppliers
  • Threat of Substitutes
  • Threat of New Entrants
• 11.4 Market Share Analysis

12. Opportunities & Strategic Analysis

• 12.1 Value Chain Analysis
• 12.2 Growth Opportunity Analysis
  • 12.2.1 Growth Opportunity by Type
  • 12.2.2 Growth Opportunity by Application
• 12.3 Emerging Trends in the Global Dissolvable Microcarrier Market
• 12.4 Strategic Analysis
  • 12.4.1 New Product Development
  • 12.4.2 Certification and Licensing
  • 12.4.3 Mergers, Acquisitions, Agreements, Collaborations, and Joint Ventures

13. Company Profiles of the Leading Players Across the Value Chain

• 13.1 Competitive Analysis Overview
• 13.2 Corning
  • Company Overview
  • Dissolvable Microcarrier Market Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 13.3 CytoNiche
  • Company Overview
  • Dissolvable Microcarrier Market Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 13.4 Tantti Laboratory
  • Company Overview
  • Dissolvable Microcarrier Market Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 13.5 IamFluidics
  • Company Overview
  • Dissolvable Microcarrier Market Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 13.6 DNP
  • Company Overview
  • Dissolvable Microcarrier Market Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing

14. Appendix

• 14.1 List of Figures
• 14.2 List of Tables
• 14.3 Research Methodology
• 14.4 Disclaimer
• 14.5 Copyright
• 14.6 Abbreviations and Technical Units
• 14.7 About Us
• 14.8 Contact Us